Blog

Melvin Chua: Honoured to be mentioned along with giants in the field of oncology

Melvin Chua/X

Dec 8, 2024, 03:40

Melvin Chua: Honoured to be mentioned along with giants in the field of oncology

Melvin Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared a post on X by ASCO:

“Very honoured to be mentioned along with giants in the field of oncology.

Many thanks to ASCO for the opportunities to volunteer and connect with the Global cancer community.”

Quoting ASCO’s post:

“Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction this quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction.”

Melvin Chua: Honoured to be mentioned along with giants in the field of oncology

More posts featuring Melvin Chua and ASCO.

Dr. Melvin L.K. Chua is a Clinician-Scientist at the NCCS and Duke-NUS Medical School, and Principal Investigator of the Precision Radiotherapeutics and Oncology Programme, Division of Medical Sciences, supported by the NMRC Clinician-Scientist Award.

He is also the Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers, Division of Radiation Oncology, and Director of the Data and Computational Science Core at the NCCS. His research is focused on phase 2-3 trials in nasopharynx (NPC) and prostate cancers (PCa).

He is also on the scientific advisory board for the NPC Guangzhou-Singapore Trial Network, a board member on the Head Neck Cancer International Group (HNCIG), and the Clinical Trials Scientific Committee Chair of HNCIG.

Dr. Chuaam’s other academic activities include his present role as the Editor-in-Chief, Annals of Nasopharynx Cancer and his previous role as the Associate Senior Editor for the Head and Neck Cancer Section of the International Journal of Radiation Oncology Biology Physics – Official journal of the American Society of Radiation Oncology.